Ameresco holder plans Rule 144 sale of 200 shares

Ameresco shareholder filed a Rule 144 notice covering the planned sale of 200 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $6,738.00 and an approximate sale date of 02/12/2026.

Rhea-AI Filing Summary

Ameresco shareholder filed a Rule 144 notice covering the planned sale of 200 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $6,738.00 and an approximate sale date of 02/12/2026.

The shares come from an exercise of stock options on 02/12/2026, paid in cash. Over the prior three months, the same account sold 100 common shares on 01/28/2026 for gross proceeds of $3,400.00 under transactions labeled as 10b5‑1 sales.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for AMRC disclose?

The Form 144 discloses a planned sale of 200 Ameresco common shares. These shares were acquired by exercising stock options for cash and are expected to be sold on the NYSE with an aggregate market value of $6,738.00.

How many Ameresco (AMRC) shares are planned to be sold under this Form 144?

The filing covers a planned sale of 200 Ameresco common shares. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with the filing listing an aggregate market value of $6,738.00 for the transaction.

How were the Ameresco (AMRC) shares in this Form 144 acquired?

The 200 Ameresco common shares were acquired on 02/12/2026 through the exercise of stock options. The filing states the nature of payment as cash, meaning the option exercise price was paid in cash at the time of acquisition.

What recent Ameresco (AMRC) share sales are disclosed in the Form 144?

The filing reports that the same account sold 100 Ameresco common shares on 01/28/2026. These were labeled as 10b5‑1 sales for Nickolas Stavropoulos and generated gross proceeds of $3,400.00 over the last three months.

Which broker is handling the planned Ameresco (AMRC) share sale?

The planned sale of 200 Ameresco common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are to be sold on the NYSE.

What representation does the seller make in the Ameresco (AMRC) Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about Ameresco’s current or prospective operations that has not been publicly disclosed, consistent with the standard representation language included in Rule 144 notices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001195025
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ameresco, Inc.
SEC File Number	001-34811
Address of Issuer	111 Speen Street, Suite 410 Framingham MASSACHUSETTS 01701
Phone	5086612200
Name of Person for Whose Account the Securities are To Be Sold	NICKOLAS STAVROPOULOS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	200	6738.00	34797456	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2026	Exercise of Stock Options	Issuer			200	02/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NICKOLAS STAVROPOULOS 111 Speen Street, Suite 410 Framingham MA 01701	Common	01/28/2026	100	3400.00

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nickolas Stavropoulos
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)